Lv4
470 积分 2025-11-11 加入
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial
20小时前
待确认
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
20小时前
已完结
Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies
20小时前
已完结
Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors
21小时前
已完结
Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval
21小时前
已完结
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
21小时前
已完结
T cell exclusion, immune privilege, and the tumor microenvironment
21小时前
已完结
Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma
22小时前
已完结
Cancer immune evasion, immunoediting and intratumour heterogeneity
22小时前
已完结
皖公网安备34019202002308
